BIMERVAX

BIOLOGICAL2 trials

Sponsors

Hipra Scientific, S.L.U

Conditions

Influenza, HumanSARS CoV 2 Infection

Phase 2

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

CompletedNCT05981846

Hipra Scientific, S.L.UInfluenza, Human, SARS CoV 2 Infection

Start: 2023-09-04End: 2023-11-06Updated: 2024-02-26

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

CompletedNCT06234956

Hipra Scientific, S.L.USARS CoV 2 Infection

Start: 2023-06-08End: 2025-09-09Updated: 2026-03-12